Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
3.670
-0.520 (-12.41%)
At close: Nov 10, 2025, 4:00 PM EST
3.780
+0.110 (3.00%)
After-hours: Nov 10, 2025, 5:35 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $126.83 million as of November 10, 2025. Its market cap has increased by 5,276.00% in one year.
Market Cap
126.83M
Enterprise Value
136.33M
1-Year Change
5,276.00%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $126.83M, an increase of 207.98%. That is a compound annual growth rate of 34.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 144.80M | 3,588.73% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |